Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | -3.76% | -9.71% | +6.23% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 39.67M 28.83M |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.08M | Net income 2025 * | -23M -16.71M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
-2.8
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
1 day | -3.76% | ||
1 week | -9.71% | ||
Current month | -10.36% | ||
1 month | -9.71% | ||
3 months | +27.39% | ||
6 months | +17.62% | ||
Current year | +6.23% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3.07 | -3.76% | 9,713 |
24-04-17 | 3.19 | -4.78% | 16,859 |
24-04-16 | 3.35 | -0.30% | 7,390 |
24-04-15 | 3.36 | -1.32% | 21,644 |
24-04-12 | 3.405 | +0.15% | 5,891 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.23% | 28.86M | |
+27.97% | 672B | |
+23.48% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.19% | 211B | |
-0.73% | 203B | |
-10.27% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- ACST Stock